COVID-19: Myocardial Injury in Survivors

Circulation. 2020 Sep 15;142(11):1120-1122. doi: 10.1161/CIRCULATIONAHA.120.049252. Epub 2020 Jul 14.

Daniel S Knight^#^{1

2}, Tushar Kotecha^#¹, Yousuf Razvi¹, Liza Chacko^{1

3}, James T Brown^{1

2}, Paramjit S Jeetley¹, James Goldring¹, Michael Jacobs¹, Lucy E Lamb^{1

4}, Rupert Negus¹, Anthony Wolff¹, James C Moon^{2

5}, Hui Xue⁶, Peter Kellman⁶, Niket Patel^#^{1

2}, Marianna Fontana^#^{1

3}

¹ Royal Free London NHS Foundation Trust, United Kingdom (D.S.K., T.K., Y.R., L.C., J.T.B., P.S.J., J.G., M.J., L.E.L., R.N., A.W., N.P., M.F.).
² Institute of Cardiovascular Science, University College London, United Kingdom (D.S.K., J.T.B., J.C.M., N.P.).
³ National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (L.C., M.F.).
⁴ Academic Department of Defence Medicine, Royal Centre for Defence Medicine, ICT Centre, Edgbaston, Birmingham, United Kingdom (L.E.L.).
⁵ Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London, United Kingdom (J.C.M.).
⁶ National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (H.X., P.K.).

^# Contributed equally.

No abstract available

Keywords: COVID-19; edema; gadolinium; magnetic resonance imaging; myocarditis; severe acute respiratory syndrome coronavirus 2; troponin.

Publication types